Alpha Blockers Linked to Prostate Cancer Relapse
A retrospective study has just been published that shows that the risk of experiencing a biochemical recurrence (PSA recurrence) after radical prostatectomy to treat prostate cancer increased significantly in men who received alpha blockers for [...]
The Really Big Factor in Prostate Cancer Deaths Is Age – Can Rationing Save Money?
Is it a subtle form of healthcare rationing with the goal of saving money at the expense of lives? Maybe that is what is going on. Older men are not economically as valuable to society [...]
Attacking Androgen Receptor Signaling In Castrate Resistant Prostate Cancer
Advanced prostate cancer eventually progresses and becomes castration resistant (CRPC) despite the fact that it is exquisitely sensitivity to androgen deprivation therapy. There has been recent evidence that prostate cancer progression at the CRPC stage [...]
On The Horizon – Some More Information & An Update On MDV3100
Many of us are aware of the newly approved drug Zytiga (abiraterone). It had demonstrated a survival advantage for men who are castrate resistant and failed chemotherapy. Zytiga was approved by the FDA in April [...]
The USPSTF Web Site Is Back & Ready For Your Comments
The web site for comments about the PSA test to the United States Preventive Services Task Force (USPSTF) is finally back in service and ready for your comments. Last night their site collapsed (I am [...]
Post Your Comments About PSA Testing With The USPSTF
It is important that we all add comments to the “Opportunity for Public Comment – Screening for Prostate Cancer: USPSTF Recommendation Statement DRAFT at the following URL https://web.archive.org/web/20111210163948/http://www.uspreventiveservicestaskforce.org:80/uspstf%5Fform3/ I chose to make the following comments: [...]